Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost.
about
Community IntraVenous Antibiotic Study (CIVAS): protocol for an evaluation of patient preferences for and cost-effectiveness of community intravenous antibiotic servicesGood practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement.Continuous clindamycin infusion, an innovative approach to treating bone and joint infectionsHome intravenous antibiotics in a tertiary care hospital in Saudi Arabia.Duration of post-surgical antibiotic therapy for adult chronic osteomyelitis: a single-centre experience.A retrospective comparison of ceftriaxone versus oxacillin for osteoarticular infections due to methicillin-susceptible Staphylococcus aureusErtapenem: review of a new carbapenem.Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review.Case files of the University of Massachusetts fellowship in medical toxicology: lethal dose of opioids contained in an elastomeric capsule labeled as vancomycin.C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option.Continuous cefazolin infusion to treat bone and joint infections: clinical efficacy, feasibility, safety, and serum and bone concentrations.Comparison of the pharmacokinetics, safety and tolerability of daptomycin in healthy adult volunteers following intravenous administration by 30 min infusion or 2 min injectionPrediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy.Should alternatives to conventional hospitalisation be promoted in an era of financial constraint?Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service.Utilizing a Modified Care Coordination Measurement Tool to Capture Value for a Pediatric Outpatient Parenteral and Prolonged Oral Antibiotic Therapy Program.Outpatient parenteral antimicrobial therapy-treated bone and joint infections in a tropical setting.Outpatient parenteral antimicrobial therapy.Economic evaluation of outpatient parenteral antimicrobial therapy: a systematic review.Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes.Safety and efficacy of outpatient parenteral antibiotic therapy in an academic infectious disease clinic.Mechanical performances of elastomers used in diffusersOutpatient parenteral antimicrobial therapy for surgery patients: A comparison with previous standard of care.High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion.Self-administration of outpatient parenteral antibiotic therapy and risk of catheter-related adverse events: a retrospective cohort study.Outpatient parenteral antimicrobial therapy.Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.Design and prospective validation of a dosing instrument for continuous infusion of vancomycin: a within-population approach.
P2860
Q26795673-40880BC3-F219-46B9-8A2A-4CFC48E71482Q27687541-AC9A13C5-0BBF-4317-9290-DD2B6B86F46BQ33559008-48C15B9A-B7E1-4152-A9CE-989785DFAAE4Q35245455-4CD7996D-1896-45C1-8FF2-EAA94D8159A1Q35355026-E6CDDD72-B1B1-4C9B-9256-528177F75649Q35745670-3E14AE3B-3E56-4E3F-953C-BF3C66854553Q36066200-D6ABF19A-9D0A-4A05-8808-7C4C79D3A8F7Q36352808-29097CBC-5201-4BF5-8EDB-6B98332A4B00Q36548408-8AFE5495-FC41-4032-8A00-AD309A86EFB7Q36687522-3A019421-821D-4339-98F1-6D041D976F9EQ37115670-F39583C4-CAED-4357-BB44-7FE0F697D0CCQ37217100-289594CA-216C-45CE-94A8-59AB646F2A2FQ37604529-1ADE71B0-DE2C-40D3-863E-ADC35FD509FCQ38099412-33EB028A-80A9-4476-9BA2-F0EEDC825965Q39200930-4CA33E0E-4E00-4ADA-AEFC-ED03ADA97E3BQ39248460-4D717DF1-90BD-4D2F-8AA2-B6449467D401Q39589461-CA42C42B-4B8C-4BDE-9032-7836FED3B7A3Q39938810-70177FFB-A546-4D52-A738-F8D378E002B0Q40106877-00D580A8-8D12-409C-8F49-80DE64D0D8E0Q40270316-578E46A8-9239-49CD-A924-2497E1E6BD82Q40504500-827C5F57-533D-4741-9403-3599C3DD7374Q42185106-381A64BD-B2DA-4D03-8EFB-0A8FCD74EF5BQ42233030-2E21B9C2-98EF-4EA2-BCE9-3BD84DCCAC98Q44991015-BB7192AF-BF64-4966-8998-DC8D8337AF90Q45928100-D1425A81-AB67-4D87-9942-E9BD5003FDF3Q50121508-E085A768-5CAC-4FB1-8DCB-88F7D0413020Q50981134-3FED38B6-BE8F-4989-9012-9FFB92D30BA8Q51047130-3CBE3096-4C0C-4FDB-8073-71CA96236F39
P2860
Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Outpatient parenteral antimicr ...... efficacy, tolerance and cost.
@en
Outpatient parenteral antimicr ...... efficacy, tolerance and cost.
@nl
type
label
Outpatient parenteral antimicr ...... efficacy, tolerance and cost.
@en
Outpatient parenteral antimicr ...... efficacy, tolerance and cost.
@nl
prefLabel
Outpatient parenteral antimicr ...... efficacy, tolerance and cost.
@en
Outpatient parenteral antimicr ...... efficacy, tolerance and cost.
@nl
P2093
P2860
P1476
Outpatient parenteral antimicr ...... efficacy, tolerance and cost.
@en
P2093
Denormandie P
Gaillard JL
Perronne C
Signoret F
P2860
P304
P356
10.1046/J.1365-2710.2001.00380.X
P577
2001-12-01T00:00:00Z